QQQ   314.39 (+0.01%)
AAPL   129.18 (+0.21%)
MSFT   213.67 (+0.31%)
FB   250.52 (+1.99%)
GOOGL   1,736.14 (+0.30%)
AMZN   3,119.11 (-0.27%)
TSLA   854.74 (+1.15%)
NVDA   526.92 (-0.21%)
BABA   244.93 (+0.80%)
CGC   34.67 (+0.14%)
GE   11.38 (-2.40%)
MU   81.34 (+0.05%)
AMD   90.38 (-0.45%)
T   29.19 (-0.34%)
NIO   58.17 (-4.44%)
F   9.92 (-2.46%)
ACB   12.74 (+6.52%)
BA   208.28 (-0.78%)
DIS   172.28 (-0.66%)
NFLX   500.11 (-0.15%)
GILD   62.67 (+0.43%)
QQQ   314.39 (+0.01%)
AAPL   129.18 (+0.21%)
MSFT   213.67 (+0.31%)
FB   250.52 (+1.99%)
GOOGL   1,736.14 (+0.30%)
AMZN   3,119.11 (-0.27%)
TSLA   854.74 (+1.15%)
NVDA   526.92 (-0.21%)
BABA   244.93 (+0.80%)
CGC   34.67 (+0.14%)
GE   11.38 (-2.40%)
MU   81.34 (+0.05%)
AMD   90.38 (-0.45%)
T   29.19 (-0.34%)
NIO   58.17 (-4.44%)
F   9.92 (-2.46%)
ACB   12.74 (+6.52%)
BA   208.28 (-0.78%)
DIS   172.28 (-0.66%)
NFLX   500.11 (-0.15%)
GILD   62.67 (+0.43%)
QQQ   314.39 (+0.01%)
AAPL   129.18 (+0.21%)
MSFT   213.67 (+0.31%)
FB   250.52 (+1.99%)
GOOGL   1,736.14 (+0.30%)
AMZN   3,119.11 (-0.27%)
TSLA   854.74 (+1.15%)
NVDA   526.92 (-0.21%)
BABA   244.93 (+0.80%)
CGC   34.67 (+0.14%)
GE   11.38 (-2.40%)
MU   81.34 (+0.05%)
AMD   90.38 (-0.45%)
T   29.19 (-0.34%)
NIO   58.17 (-4.44%)
F   9.92 (-2.46%)
ACB   12.74 (+6.52%)
BA   208.28 (-0.78%)
DIS   172.28 (-0.66%)
NFLX   500.11 (-0.15%)
GILD   62.67 (+0.43%)
QQQ   314.39 (+0.01%)
AAPL   129.18 (+0.21%)
MSFT   213.67 (+0.31%)
FB   250.52 (+1.99%)
GOOGL   1,736.14 (+0.30%)
AMZN   3,119.11 (-0.27%)
TSLA   854.74 (+1.15%)
NVDA   526.92 (-0.21%)
BABA   244.93 (+0.80%)
CGC   34.67 (+0.14%)
GE   11.38 (-2.40%)
MU   81.34 (+0.05%)
AMD   90.38 (-0.45%)
T   29.19 (-0.34%)
NIO   58.17 (-4.44%)
F   9.92 (-2.46%)
ACB   12.74 (+6.52%)
BA   208.28 (-0.78%)
DIS   172.28 (-0.66%)
NFLX   500.11 (-0.15%)
GILD   62.67 (+0.43%)
Log in
NASDAQ:VIR

Vir Biotechnology News Headlines

$38.67
+2.18 (+5.97 %)
(As of 01/15/2021 09:58 AM ET)
Add
Compare
Today's Range
$36.70
Now: $38.67
$39.08
50-Day Range
$26.34
MA: $29.21
$35.55
52-Week Range
$14.25
Now: $38.67
$75.00
Volume5,925 shs
Average Volume1.45 million shs
Market Capitalization$4.93 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Vir Biotechnology (NASDAQ VIR) News Headlines Today

Source:
SourceHeadline
Wall Street Sees Vir Biotechnology Bouncing HardWall Street Sees Vir Biotechnology Bouncing Hard
marketbeat.com - September 16 at 10:11 AM
Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for ChronicGilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic
bloomberg.com - January 15 at 12:15 AM
Vir Biotechnology (VIR) Shares Cross Above 200 DMAVir Biotechnology (VIR) Shares Cross Above 200 DMA
nasdaq.com - January 14 at 7:04 PM
Vir Biotechnology (NASDAQ:VIR) Stock Price Up 10.9%Vir Biotechnology (NASDAQ:VIR) Stock Price Up 10.9%
americanbankingnews.com - January 13 at 9:41 PM
Herbert Virgin Sells 3,805 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) StockHerbert Virgin Sells 3,805 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) Stock
americanbankingnews.com - January 13 at 8:50 PM
Vir Biotechnology (NASDAQ:VIR) versus Precision BioSciences (NASDAQ:DTIL) Financial ContrastVir Biotechnology (NASDAQ:VIR) versus Precision BioSciences (NASDAQ:DTIL) Financial Contrast
americanbankingnews.com - January 13 at 5:16 AM
Interesting VIR Put And Call Options For February 19thInteresting VIR Put And Call Options For February 19th
nasdaq.com - January 12 at 3:11 PM
GSK, Vir to test antibody for COVID-19 treatmentGSK, Vir to test antibody for COVID-19 treatment
msn.com - January 12 at 6:37 AM
TOP NEWS: GSK, Vir To Probe Second Virus Antibody In NHS-Backed TrialTOP NEWS: GSK, Vir To Probe Second Virus Antibody In NHS-Backed Trial
lse.co.uk - January 12 at 6:37 AM
BRIEF-GSK, Vir Biotechnology Announce Study To Evaluate Vir-7832 In Early Treatment Of COVID-19BRIEF-GSK, Vir Biotechnology Announce Study To Evaluate Vir-7832 In Early Treatment Of COVID-19
reuters.com - January 12 at 6:37 AM
First Week of July 16th Options Trading For Vir BiotechnologyFirst Week of July 16th Options Trading For Vir Biotechnology
nasdaq.com - January 11 at 3:35 PM
Noteworthy Monday Option Activity: VIR, NBIX, GRWGNoteworthy Monday Option Activity: VIR, NBIX, GRWG
nasdaq.com - January 11 at 3:35 PM
JPM Day 1: The 19-day Covid deal, how global-focused biotech wins, last-minute news and moreJPM Day 1: The 19-day Covid deal, how global-focused biotech wins, last-minute news and more
bizjournals.com - January 11 at 10:45 AM
Vir Biotechnology (NASDAQ:VIR) Stock Price Down 5.8%Vir Biotechnology (NASDAQ:VIR) Stock Price Down 5.8%
americanbankingnews.com - January 8 at 8:46 PM
Critical Comparison: Axcella Health (NASDAQ:AXLA) vs. Vir Biotechnology (NASDAQ:VIR)Critical Comparison: Axcella Health (NASDAQ:AXLA) vs. Vir Biotechnology (NASDAQ:VIR)
americanbankingnews.com - January 8 at 7:30 PM
Vir Biotechnology Target of Unusually Large Options Trading (NASDAQ:VIR)Vir Biotechnology Target of Unusually Large Options Trading (NASDAQ:VIR)
americanbankingnews.com - January 8 at 1:10 PM
Economic Forecast: Where biotech goes next after a banner yearEconomic Forecast: Where biotech goes next after a banner year
bizjournals.com - January 8 at 9:10 AM
Vir Biotechnology (NASDAQ:VIR) Trading 11.4% Higher Vir Biotechnology (NASDAQ:VIR) Trading 11.4% Higher
americanbankingnews.com - January 7 at 7:00 PM
OHSUs HIV vaccine candidate begins first clinical trial in humansOHSU's HIV vaccine candidate begins first clinical trial in humans
bizjournals.com - January 6 at 6:45 PM
Vir Biotechnology Announces Initiation of Phase 1 Clinical Trial to Evaluate a Novel Vaccine PlatformVir Biotechnology Announces Initiation of Phase 1 Clinical Trial to Evaluate a Novel Vaccine Platform
finance.yahoo.com - January 6 at 8:40 AM
Vir Biotechnology to Present at 39th Annual J.P. Morgan Healthcare ConferenceVir Biotechnology to Present at 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 5 at 8:28 AM
Varun Grover, Vir Das Stand in Solidarity With Comedian Held for Indecent Remarks on Hindu DeitiesVarun Grover, Vir Das Stand in Solidarity With Comedian Held for 'Indecent Remarks' on Hindu Deities
msn.com - January 4 at 3:28 AM
Reviewing Kodiak Sciences (NASDAQ:KOD) & Vir Biotechnology (NASDAQ:VIR)Reviewing Kodiak Sciences (NASDAQ:KOD) & Vir Biotechnology (NASDAQ:VIR)
americanbankingnews.com - January 1 at 5:12 PM
Zacks: Brokerages Expect Vir Biotechnology, Inc. (NASDAQ:VIR) Will Post Quarterly Sales of $2.65 MillionZacks: Brokerages Expect Vir Biotechnology, Inc. (NASDAQ:VIR) Will Post Quarterly Sales of $2.65 Million
americanbankingnews.com - January 1 at 2:32 AM
 Brokerages Anticipate Vir Biotechnology, Inc. (NASDAQ:VIR) to Post -$0.72 Earnings Per Share Brokerages Anticipate Vir Biotechnology, Inc. (NASDAQ:VIR) to Post -$0.72 Earnings Per Share
americanbankingnews.com - December 30 at 5:14 PM
Vir, biotech firm researching coronavirus, to take part of Dropbox HQVir, biotech firm researching coronavirus, to take part of Dropbox HQ
msn.com - December 29 at 11:12 PM
$2.65 Million in Sales Expected for Vir Biotechnology, Inc. (NYSE:VIR) This Quarter$2.65 Million in Sales Expected for Vir Biotechnology, Inc. (NYSE:VIR) This Quarter
americanbankingnews.com - December 29 at 2:46 AM
Vir Biotechnology, Inc. (NYSE:VIR) Expected to Post Earnings of -$0.72 Per ShareVir Biotechnology, Inc. (NYSE:VIR) Expected to Post Earnings of -$0.72 Per Share
americanbankingnews.com - December 27 at 1:20 PM
Vir Biotechnology, Inc. (NYSE:VIR) Receives Average Rating of "Hold" from AnalystsVir Biotechnology, Inc. (NYSE:VIR) Receives Average Rating of "Hold" from Analysts
americanbankingnews.com - December 26 at 5:26 PM
Vir Biotechnologys (VIR) Sell Rating Reaffirmed at Robert W. BairdVir Biotechnology's (VIR) Sell Rating Reaffirmed at Robert W. Baird
americanbankingnews.com - December 25 at 8:04 AM
Insider Selling: Vir Biotechnology, Inc. (NYSE:VIR) EVP Sells 3,805 Shares of StockInsider Selling: Vir Biotechnology, Inc. (NYSE:VIR) EVP Sells 3,805 Shares of Stock
americanbankingnews.com - December 23 at 8:48 PM
Are Options Traders Betting on a Big Move in in Vir Biotechnology (VIR) Stock?Are Options Traders Betting on a Big Move in in Vir Biotechnology (VIR) Stock?
finance.yahoo.com - December 22 at 12:55 PM
The Daily Biotech Pulse: FDA Nod For Amgens Biosimilar, Modernas Vaccine Vote, Mesoblast Sinks On DataThe Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data
finance.yahoo.com - December 18 at 10:52 AM
The Daily Biotech Pulse: FDA Nod For Amgens Biosimilar, Modernas Vaccine Vote, Mesoblast Sinks On DataThe Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data
finance.yahoo.com - December 18 at 10:52 AM
Vir, GSKs experimental COVID-19 treatment moves into a Phase 3 clinical trialVir, GSK's experimental COVID-19 treatment moves into a Phase 3 clinical trial
finance.yahoo.com - December 18 at 10:52 AM
Vir, GSKs experimental COVID-19 treatment moves into a Phase 3 clinical trialVir, GSK's experimental COVID-19 treatment moves into a Phase 3 clinical trial
finance.yahoo.com - December 18 at 10:52 AM
Vir Biotechnology Appoints Jeffrey Hatfield to its Board of DirectorsVir Biotechnology Appoints Jeffrey Hatfield to its Board of Directors
finance.yahoo.com - December 10 at 12:33 PM
Future Vaccines Have High Barrier to Cross, Vir CEO SaysFuture Vaccines Have 'High Barrier' to Cross, Vir CEO Says
msn.com - December 5 at 9:22 PM
Is Vir Biotechnology  (VIR) A Good Stock To Buy Now?Is Vir Biotechnology (VIR) A Good Stock To Buy Now?
finance.yahoo.com - December 2 at 8:16 PM
Here are the latest updates on coronavirus treatments and the Moderna, Pfizer and other vaccinesHere are the latest updates on coronavirus treatments and the Moderna, Pfizer and other vaccines
msn.com - November 30 at 3:34 PM
Biotech IPOs close to beating Covid-19Biotech IPOs close to beating Covid-19
nasdaq.com - November 25 at 6:43 PM
Peter Thiel Gets Board Seat at AbCellera as IPO NearsPeter Thiel Gets Board Seat at AbCellera as IPO Nears
msn.com - November 19 at 1:09 PM
Analysts Have Just Cut Their Vir Biotechnology, Inc. (NASDAQ:VIR) Revenue Estimates By 20%Analysts Have Just Cut Their Vir Biotechnology, Inc. (NASDAQ:VIR) Revenue Estimates By 20%
finance.yahoo.com - November 16 at 12:33 PM
Earnings Update: Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported And Analysts Are Trimming Their ForecastsEarnings Update: Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported And Analysts Are Trimming Their Forecasts
finance.yahoo.com - November 13 at 12:08 PM
As other Covid drugs grab headlines, this Bay Area company picks its spot to defeat virusAs other Covid drugs grab headlines, this Bay Area company picks its spot to defeat virus
bizjournals.com - November 10 at 8:38 PM
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2020 Financial ResultsVir Biotechnology Provides Corporate Update and Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 10 at 8:38 PM
Vir Biotechnology: Small-Cap Player That Lets Others Do The Heavy LiftingVir Biotechnology: Small-Cap Player That Lets Others Do The Heavy Lifting
seekingalpha.com - November 7 at 12:54 PM
Vir Biotechnology Publishes New Research Characterizing Variation in the SARS-CoV-2 Spike Protein and Virulence of a Prevalent Immune Evasion Variant, N439KVir Biotechnology Publishes New Research Characterizing Variation in the SARS-CoV-2 Spike Protein and Virulence of a Prevalent Immune Evasion Variant, N439K
finance.yahoo.com - November 6 at 11:46 AM
Lilly Races Ahead on a Single-Antibody Covid-19 TreatmentLilly Races Ahead on a Single-Antibody Covid-19 Treatment
bloomberg.com - October 29 at 6:53 AM
27 pharma execs involved in the hunt for COVID-19 vaccines have raked in more than $1 billion by selling stock this year. Heres whos cashed in the most from Regeneron ...27 pharma execs involved in the hunt for COVID-19 vaccines have raked in more than $1 billion by selling stock this year. Here's who's cashed in the most from Regeneron ...
msn.com - October 28 at 5:48 PM
Vir Biotechnology to Provide Corporate Update and  Report Third Quarter 2020 Financial Results on November 10, 2020Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2020 Financial Results on November 10, 2020
finance.yahoo.com - October 27 at 7:41 PM
This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.